Impact on monoclonal antibody production in murine hybridoma cell cultures of adenosine receptor antagonists and phosphodiesterase inhibitors

Geoffrey F Kelso, Shahid Kazi, Simon J Harris, Reinhard I Boysen, Mohammad Chowdhury, Milton T W Hearn

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)


The effects of different adenosine receptor antagonists and cyclic nucleotide phosphodiesterase (PDE) inhibitors on monoclonal antibody (mAb) titer and cell viability of murine hybridoma cells in culture were measured as part of our investigations to discover additives that enhance mAb production. Specific adenosine receptor antagonists and PDE inhibitors were found to enhance or decrease the titer of immunoglobulin G1 (IgG1) mAbs relative to negative controls, depending on the specific compound and cell line employed. The observed enhancements or decreases in IgG1 mAb titer appeared to be mainly due to an increase or decrease in specific productivity rates (ng mAb/cell), respectively. The different effects of the selective adenosine antagonists suggest that antagonism at the level of the adenosine A2A and A1 or the adenosine A3 receptors result in either enhancement or suppression of IgG1 mAb production by hybridoma cells. Overall, these studies have identified hitherto unknown activities of specific adenosine antagonists and PDE inhibitors which indicate they may have valuable roles as cell culture additives in industrial biomanufacturing processes designed to enhance the yields of mAbs or other recombinant proteins produced by mammalian cell culture procedures.

Original languageEnglish
Pages (from-to)540-544
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Issue number2
Publication statusPublished - 15 Jan 2016


  • Adenosine antagonist
  • Hybridoma
  • Monoclonal antibody
  • Phosphodiesterase inhibitor

Cite this